Peter Keeling, Founder and CEO, Diaceutics
Founder and CEO of Diaceutics Peter Keeling is one of the finalists for this year’s EY Entrepreneur of the Year Award in the international category.
The event is now in its 21st year and is celebrating the theme of ‘Ambition’ for 2018.
Peter Keeling founded Diaceutics in 2005 and has been named as a finalist in the international category joining 23 others. The winner will be announced in October.
Diaceutics works with the world’s top pharmaceutical companies and uses a global network if laboratories to help deliver better testing and a more efficient diagnosis process for patients resulting in better treatments.
Peter has been leading the company since it began 13 years ago with the organisation helping over half-a-million customers with life-threatening diseases get the best possible treatments they can.
The company has seen 60% growth year-on-year for the last three years and works in the top 10 markets in the world.
Peter commented: “It is an absolute honour to be named as a finalist in the EY Entrepreneur of the Year programme, which is widely recognised and well respected across the globe. To be considered among such a high calibre of entrepreneurs and businesses is incredible.
“This year’s ‘Ambition’ theme is something that resonates with everyone who works at Diaceutics and makes the achievement extra special. We are a very ambitious organisation which is constantly striving, and succeeding, at getting the right patients to the right treatment at the right time.”